BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 19242117)

  • 1. REDD1, a new Ras oncogenic effector.
    Smith ER; Xu XX
    Cell Cycle; 2009 Mar; 8(5):675-6. PubMed ID: 19242117
    [No Abstract]   [Full Text] [Related]  

  • 2. [The cooperation between p53 and Ras in tumorigenesis].
    Wei YY; Hou J; Tang WR; Luo Y
    Yi Chuan; 2012 Dec; 34(12):1513-21. PubMed ID: 23262097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ras and TGF-β signaling enhance cancer progression by promoting the ΔNp63 transcriptional program.
    Vasilaki E; Morikawa M; Koinuma D; Mizutani A; Hirano Y; Ehata S; Sundqvist A; Kawasaki N; Cedervall J; Olsson AK; Aburatani H; Moustakas A; Miyazono K; Heldin CH
    Sci Signal; 2016 Aug; 9(442):ra84. PubMed ID: 27555661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide SNP analysis of Tg.AC transgenic mice reveals an oncogenic collaboration between v-Ha-ras and Ink4a, which is absent in p53 deficiency.
    Leder A; McMenamin J; Zhou F; Moran JL; Beier DR; Leder P
    Oncogene; 2008 Apr; 27(17):2456-65. PubMed ID: 17952114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular senescence induced by p53-ras cooperation is independent of p21waf1 in murine embryo fibroblasts.
    Castro ME; del Valle Guijarro M; Moneo V; Carnero A
    J Cell Biochem; 2004 Jun; 92(3):514-24. PubMed ID: 15156563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Murine fibroblasts lacking p21 undergo senescence and are resistant to transformation by oncogenic Ras.
    Pantoja C; Serrano M
    Oncogene; 1999 Sep; 18(35):4974-82. PubMed ID: 10490832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunophenotype, ras oncogenes and p53 onco-suppressor gene in benzo(a)pyrene induced malignant soft tissue tumours in Wistar rats.
    Stefanou DG; Nonni AV; Kalpouzos G; Evangelou A; Agnantis NJ
    In Vivo; 1998; 12(5):511-21. PubMed ID: 9827359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hedgehog signaling and the Gli code in stem cells, cancer, and metastases.
    Ruiz i Altaba A
    Sci Signal; 2011 Nov; 4(200):pt9. PubMed ID: 22114144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic Ras-mediated downregulation of Gadd153/CHOP is required for Ras-induced cellular transformation.
    Rong R; Montalbano J; Jin W; Zhang J; Garling M; Sheikh MS; Huang Y
    Oncogene; 2005 Jul; 24(30):4867-72. PubMed ID: 15870698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of cellular senescence by oncogenic RAS.
    Gupta R; Wajapeyee N
    Methods Mol Biol; 2013; 1048():127-33. PubMed ID: 23929102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting RAS: The Elusive Prize.
    Bates SE
    Clin Cancer Res; 2015 Apr; 21(8):1796. PubMed ID: 25878359
    [No Abstract]   [Full Text] [Related]  

  • 12. Oncogenic ras activates the ARF-p53 pathway to suppress epithelial cell transformation.
    Lin AW; Lowe SW
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5025-30. PubMed ID: 11309506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer: The Ras renaissance.
    Ledford H
    Nature; 2015 Apr; 520(7547):278-80. PubMed ID: 25877186
    [No Abstract]   [Full Text] [Related]  

  • 14. Cellular DNA, ras p21 and p53 expression in the carcinogenesis of adenomatous colorectal polyps.
    Zhang X; Wu W; Lu H; Lu G; Zuo L
    Anal Quant Cytol Histol; 1999 Oct; 21(5):449-53. PubMed ID: 10560529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of p21 and p53 expression in gastric cancer.
    Seo YH; Joo YE; Choi SK; Rew JS; Park CS; Kim SJ
    Korean J Intern Med; 2003 Jun; 18(2):98-103. PubMed ID: 12872447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context.
    Guerra C; Mijimolle N; Dhawahir A; Dubus P; Barradas M; Serrano M; Campuzano V; Barbacid M
    Cancer Cell; 2003 Aug; 4(2):111-20. PubMed ID: 12957286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.
    Sarkisian CJ; Keister BA; Stairs DB; Boxer RB; Moody SE; Chodosh LA
    Nat Cell Biol; 2007 May; 9(5):493-505. PubMed ID: 17450133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-137 Modulates a Tumor Suppressor Network-Inducing Senescence in Pancreatic Cancer Cells.
    Neault M; Mallette FA; Richard S
    Cell Rep; 2016 Mar; 14(8):1966-78. PubMed ID: 26904954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. K-ras mutations and p53 alterations in neoplastic and nonneoplastic lesions associated with longstanding ulcerative colitis.
    Chaubert P; Benhattar J; Saraga E; Costa J
    Am J Pathol; 1994 Apr; 144(4):767-75. PubMed ID: 8160776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain cancer stem-like cell genesis from p53-deficient mouse astrocytes by oncogenic Ras.
    Lee JS; Gil JE; Kim JH; Kim TK; Jin X; Oh SY; Sohn YW; Jeon HM; Park HJ; Park JW; Shin YJ; Chung YG; Lee JB; You S; Kim H
    Biochem Biophys Res Commun; 2008 Jan; 365(3):496-502. PubMed ID: 18021740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.